Page last updated: 2024-09-05

dabigatran and Gastrointestinal Hemorrhage

dabigatran has been researched along with Gastrointestinal Hemorrhage in 154 studies

Research

Studies (154)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's115 (74.68)24.3611
2020's39 (25.32)2.80

Authors

AuthorsStudies
Chao, TF; Chen, MC; Chen, SW; Chu, PH; Chung, CM; Kuan, FC; Lin, YS; Lip, GYH; Wu, M; Wu, VC1
An, J; Duan, L; Huang, CW; Lee, MS; Sim, JJ1
Ágústsson, AS; Björnsson, ES; Guðmundsdóttir, BR; Hreinsson, JP; Ingason, AB; Lund, SH; Önundarson, PT; Pálsson, DA; Reynisson, IE; Rumba, E1
Fu, G; Liu, Z; Wang, Y; Yin, L; Zhang, K1
Bitton, E; Clark, NP; Coates, J; Delate, T; Fink, KM; Hendje, A; Knowles, C; Ly, S; Olson, KL1
Abe, K; Amano, H; Asaoka, Y; Honda, T; Kodashima, S; Komatsuda, S; Kozuma, K; Manabe, D; Tanaka, A; Yamamoto, H; Yamamoto, T; Yanagisawa, D1
Aigner, E; Balcar, L; Bartl, S; Datz, C; Gensluckner, S; Hametner-Schreil, S; Hofer, H; Lampichler, K; Lindorfer, A; Mandorfer, M; Pomej, K; Reiberger, T; Schäfer, B; Scheiner, B; Schöfl, R; Semmler, G; Trauner, M; Zoller, H1
Al Kasasbeh, M; Al-Abdouh, A; Barbarawi, M; Barbarawi, O; Corcoran, J; Mhanna, M; Obeidat, K; Pickett, CC1
Chen, C; Chen, X; Huang, N; Jiang, S; Lv, M; Wu, T; Zhang, J1
Agustsson, AS; Bjornsson, ES; Gudmundsdottir, BR; Hreinsson, JP; Ingason, AB; Lund, SH; Onundarson, PT; Palsson, DA; Reynisson, IE; Rumba, E1
Burgos-Gonzalez, A; Huerta, C; Peñalver, MJ; Pulido, J; Sordo, L; Soriano, LC1
Björnsson, ES; Hreinsson, JP; Ingason, AB1
Arioli, D; Athanasiou, A; Ballestri, S; Capitelli, M; Cappi, C; Coluccio, V; Di Girolamo, M; Marietta, M; Marrazzo, A; Romagnoli, E1
Kalka, I; Kornowski, R; Rossman, H; Segal, E; Talmor-Barkan, Y; Witberg, G; Yacovzada, NS1
Brigida, M; Candelli, M; Gabrielli, M; Ojetti, V; Petruzziello, C; Saviano, A1
Abraham, NS; Barkun, AN; Douketis, J; Hansen-Barkun, C; Kaplovitch, E; Liederman, Z; Majid, A; Martel, M; Schulman, S; Spyropoulos, AC1
Björck, F; Jansson, M; Norrving, B; Renlund, H; Själander, A; Själander, S; Sjögren, V1
Malý, J; Moudallel, S; Rydant, S; Steurbaut, S; van den Eynde, C1
Apolinario, M; Firth, C; Keddis, MT; Lim, ES; Shamoun, F; Zhang, N1
Al-Hussainy, N; Kragholm, KH; Lip, GYH; Lundbye-Christensen, S; Pareek, M; Riahi, S; Therkelsen, SK; Torp-Pedersen, C1
Butt, JH; Fosbøl, EL; Garcia, D; Køber, L; Li, A; Peterson, ED; Torp-Pedersen, C; Xian, Y1
Huggan, P; Humphries, K; Martynoga, R; Stiles, M1
Bolek, T; Galajda, P; Kubisz, P; Mokáň, M; Samoš, M; Škorňová, I; Staško, J1
Almenar-Bonet, L; Barge-Caballero, E; Blasco-Peiró, T; Carrasco Ávalos, F; Crespo-Leiro, MG; de la Fuente-Galán, L; Díaz-Molina, B; Díez-López, C; González-Vilchez, F; López Granados, A; López-Vilella, R; Mirabet-Pérez, S; Rangel-Sousa, D; Segovia-Cubero, J; Zatarain-Nicolás, E1
Młodawska, E; Sobkowicz, B; Tomaszuk-Kazberuk, A; van Ryn, J; Łopatowska, P1
Bernstein, RA; Clark, CL; Douketis, J; Fanikos, J; Fermann, GJ; Fiore, GJ; Frost, A; Jahromi, B; Johnson, C; Merli, G; Peacock, WF; Pollack, CV; Silber, S; Villines, TC1
Albrecht, H; Hagel, AF; Konturek, PC; Maass, LS; Neurath, MF; Raithel, M1
Edwards, JK; Lund, JL; Poole, C; Simpson, RJ; Stürmer, T; Webster-Clark, M2
Ham, SA; Micic, D; Sengupta, N; Tapaskar, N1
Brahmbhatt, B; Devani, K; Radadiya, D; Reddy, C1
Chan, FK; Guo, CL; Lam, KL; Lau, LH; Mak, JW; Ng, SC; Wong, GL; Wong, SH; Yip, TC1
Côté, R; Dorais, M; Martel, MJ; Perreault, S; Qazi, JZ; Schnitzer, ME1
Oh, HJ; Park, BJ; Ryu, KH; Yoon, BH1
Choi, EK; Han, KD; Jung, JH; Kwon, S; Lee, SR; Lip, GYH; Oh, S1
Barnes, GD; Cuker, A; Dawwas, GK; Dietrich, E; Leonard, CE; Lewis, JD1
Agudo-Fernández, S; Calvo Morillas, I; Castaño Milla, C; González Blanco, A; Olmos Jerez, JA; Sancho Del Val, L1
Han, KD; Kim, BS; Kim, HK; Kim, YJ; Lee, H; Lee, HJ; Lee, SP; Park, JB1
Benamouzig, R; Deutsch, D; Fauchier, L; Guenoun, M1
Jiang, H; Jiang, Y; Lv, J; Ma, H; Zeng, H1
Deitelzweig, S; Dhamane, AD; Ferri, M; Jiang, J; Kang, A; Keshishian, AV; Klem, C; Lip, GYH; Luo, X; Yuce, H; Zhang, Y1
Chen, J; Chen, M; Fang, Z; Jiang, S; Lv, M; Qian, J; Wu, S; Xu, W; Zeng, Z; Zhang, J1
Burr, N; Corp, A; Kane, JS; Lummis, K; Sood, R; Subramanian, V1
Ay, C; Domanovits, H; Levy, JH; Sengoelge, G; Simon, A; Spiel, AO1
Chan, KA; Chen, HM; Lai, CL; Liao, MT; Lin, TT1
Barkun, AN; Dorreen, A; Huynh, T; Martel, M; Miller, CS1
Flint, R; Hamer, P; Trip, J1
Kido, K; Scalese, MJ1
Hu, SJ; Wu, T; Xu, WW1
Jolobe, OM1
Lip, GYH; Makaritsis, K; Michel, P; Ntaios, G; Papavasileiou, V; Vemmos, K1
Bézie, Y; Bourguignon, S; Chevalier, D; Jamet, N; Paubel, P; Thivilliers, AP1
Brodie, MM; Newman, JC; Rockey, DC; Smith, T1
Akitsu, K; Fujino, T; Ikeda, T; Koike, H; Koike, M; Shinohara, M; Suzuki, T; Yao, S; Yuzawa, H1
Doctor, N; Leung, S; Mourafetis, J1
Martínez González, J; Rodríguez de Santiago, E; Sierra Morales, M1
Aisenberg, J; Brueckmann, M; Chatterjee-Murphy, P; Connolly, S; Desai, J; Ezekowitz, M; Flack, KF; Ilgenfritz, J; Kolb, JM; Reilly, P; Wallentin, LC1
Abe, K; Aoyagi, H; Isono, A; Kita, H; Kodashima, S; Kozuma, K; Maruyama, K; Watari, Y; Yamamoto, T1
Becker, M; Ganter, C; Hegemann, I; Müller, D; Spahn, DR; Widmer, CC1
Arena, G; Baratta, A; Bianchi, S; Catarzi, S; Conti, A; Covelli, A; Dell'Amico, I; Mazzucchelli, M; Molesti, D; Orlandi, G; Pampana, A; Perrotta, ME; Tognarelli, A; Torri, T1
Bai, Y; Carmo, J; Esteve-Pastor, MA; Lip, GYH; Marín, F; Orenes-Piñero, E; Proietti, M; Rivera-Caravaca, JM; Roldán, V; Romanazzi, I; Romiti, GF1
Chang, SH; Chu, PH; Kuo, CF; Tseng, HJ; Wang, CL; Wen, MS; Wu, VC1
Alvarez-Madrazo, S; Bennie, M; Mueller, T; Robertson, C; Wu, O1
Chung, CP; Daugherty, JR; Dupont, WD; Murray, KT; Ray, WA; Smalley, WE; Stein, CM1
Aisenberg, J; Elsaesser, A; Glund, S; Huisman, MV; Klok, FA; Lopes, RD; Pollack, CV; Reilly, P; Van der Wall, SJ; van Ryn, J1
Guo, X; Liu, Y; Sun, Z; Xu, Y; Zhang, Y1
Connolly, SJ; Siegal, DM1
Ahn, JY; Bang, CS; Cho, YK; Joo, MK; Jung, HK; Kim, BJ; Kim, BW; Kim, JS; Lee, BE; Lee, JH; Park, CH; Park, JM; Yang, HJ1
Fleddermann, AM; Hayes, CH; Magalski, A; Main, ML1
Abouelfath, A; Bénichou, J; Blin, P; Cottin, Y; Droz, C; Dureau-Pournin, C; Lassalle, R; Mismetti, P; Moore, N1
Chen, H; Deng, Y; Li, S; Tong, Y; Zou, L1
Belk, KW; Nautiyal, A; Singh, S1
Holm, J; Taskiran, M1
Reichman, ME; Southworth, MR; Unger, EF1
Callréus, T; Due, KM; Larsen, TB; Lip, GY; Rasmussen, LH; Rosenzweig, M; Skjøth, F1
Aisenberg, J; Desai, J; Kolb, JM; Weitz, JI1
Hallows, KR; Henry, BL; Maw, TT; Nolin, TD; Pastor-Soler, NM; Singh, T; Unruh, ML1
Brardjanian, S; Coton, T; Diallo, I; Guisset, M; Jourdan, S; Mallaret, C1
Aisenberg, J; Desai, J; Granger, CB; Weitz, JI1
Baron, TH; Kamath, PS; McBane, RD1
Keighley-Jones, L; Nash, MJ; Pike, G; Thachil, J1
Bell, S; Dawes, M; Nand, J1
Braun, G; Messmann, H1
Adam, G; Akbal, E; Asik, M; Bilen, Oİ; Binnetoglu, E; Gunes, F; Sen, H; Temiz, A; Ukinc, K1
González-Rico, MA; Juan-García, I; Miguel-Carrasco, A; Puchades-Montesa, MJ; Ramos-Tomás, C; Ribés-Cruz, JJ; Solís-Salguero, MA; Tejedor-Alonso, S; Tomás-Simó, P; Torregrosa-Maicas, I; Zambrano-Esteves, P1
Celik, S; Sipahi, I; Tozun, N1
Katz, MH1
Bastovansky, A; Finsterer, J; Paul, G; Stöllberger, C1
Davis, M; Kabra, R; Kimmons, LA; Oliphant, CS; Segars, BV1
Ditch, K; Miller, MA; Ross, B; Tran, M1
Carter, A; Corbett, S; George, M; Sarda, P1
Chintala, M; Keohane, C; Li, Q; Ni, W; O'Neill, K; Shang, J; Wang, M; Wei, H1
Henry, BL; Kumar, R; Smith, RE1
Hess, T; Konturek, P1
Ellis, MH1
Berla, M; Feinberg, J; Grabowitz, L; Levy, Y; Rotman-Pikielny, P1
Chrischilles, E; Cram, P; Jones, M; Mazur, A; Vaughan Sarrazin, MS1
Brueckmann, M; Clemens, A; Konstantinides, S; Lip, GY; Noack, H; Strack, A1
Husein, H; Samo, S; Sherid, M; Sifuentes, H; Spurr, C; Sridhar, S; Sulaiman, S; Thiruvaiyaru, D; Tupper, R1
Goulding, MR; Graham, DJ; Houstoun, M; Kelman, JA; Levenson, M; MaCurdy, TE; Mott, K; Reichman, ME; Sheu, TC; Southworth, MR; Wernecke, M; Worrall, C; Zhang, R1
Campbell, P; Lam, T; Nguyen, C; Tran, TH1
Feuerstein, JD; Ketwaroo, GA; Leffler, DA; Patwardhan, VR; Sengupta, N; Tapper, EB; Thaker, AM1
Hennes, O; Nyby, S1
Ali, A; Assaly, R; Hamouda, D; Khan, A; Mbaso, C; Paul, S; Prashar, R; Shah, S1
Loffredo, L; Perri, L; Violi, F1
Husein, H; Samo, S; Sherid, M; Sifuentes, H; Spurr, C; Sridhar, S; Sulaiman, S; Tupper, R1
Abe, J; Kato, Y; Kinosada, Y; Nagasawa, H; Nakamura, M; Nakayama, Y; Suzuki, T; Suzuki, Y; Ueda, N; Umetsu, R1
Abraham, NS; Alexander, GC; Crown, W; Haas, LR; Heien, H; Shah, ND; Singh, S1
Alexander, GC; Chang, HY; Singh, S; Tang, W; Zhou, M1
Amato, A; Dentali, F; Dumonceau, JM; Paggi, S; Radaelli, F; Repici, A; Rondonotti, E1
Chan, EW; He, Y; Lau, WC; Leung, WK; Mok, MT; Tong, TS; Wong, IC1
Fang, G; Farley, JF; Gehi, AK; Lauffenburger, JC; Rhoney, DH1
Beavers, C; Pahs, L; Schuler, P1
Berry, A; Ehrlich, C; Tsu, LV; Wald, E1
Jones, JM; Leedahl, DD; Ryan, HM; Tieszen, M1
Avgil-Tsadok, M; Behlouli, H; Eisenberg, MJ; Essebag, V; Jackevicius, CA; Pilote, L; Rahme, E1
Srivali, N; Thongprayoon, C; Ungprasert, P1
Azimi, N; Forest, CP; Holden, A1
Di Minno, A; Di Minno, G; Spadarella, E; Spadarella, G; Tremoli, E1
Bouget, J; Oger, E1
Chan, YH; Chang, SH; Kuo, CT; Lee, HF; See, LC; Tu, HT; Wu, LS; Yeh, YH; Yen, KC1
Al-Khalili, F; Benson, L; Lindström, C1
Dolginsky, M; Kym, E; Nolting, L; Orrico, KB; Romanelli, RJ1
Anand, S; Chan, EW; He, Y; Leung, WK; Li, X; Siu, CW; Wong, IC1
Gauthier-Lewis, ML; Riley, TR; Riley, TT; Sanchez, CK1
Aksoy, H; Ata, N; Ayturk, M; Dal, K; Ozkan, S; Ozturk, M; Şabanoglu, C; Tanalp, AC; Topaloglu, C; Yavuz, B; Yavuz, BB1
Battat, E; Bitterman, H; Dotan, SG; Eikelboom, JW; Ellis, MH; Ginsberg, JS; Hammerman, A; Hirsh, J; Neuman, T1
Alhashem, HM; Avendano, C; Hayes, BD; Winters, ME1
Berger, K; Lesch, CA; Sin, JH1
Milling, TJ; Spyropoulos, AC2
Kawasugi, K; Kita, H; Kuyama, Y; Shirai, T; Yamamoto, T1
Chan, YH; Chang, SH; Kuo, CT; Lee, HF; See, LC; Tu, HT; Wu, LS; Yeh, YH1
Pan, H; Wang, L; Xie, Y1
Chillarige, Y; Goulding, MR; Graham, DJ; Hsueh, YH; Izem, R; Kelman, JA; Liao, J; MaCurdy, TE; Mott, K; Reichman, ME; Southworth, MR; Wei, Y; Wernecke, M; Worrall, C1
Aisenberg, J; Brueckmann, M; Chatterjee, P; Connolly, S; Desai, J; Ezekowitz, M; Flack, KF; Ilgenfritz, J; Kolb, JM; Reilly, P; Wallentin, LC; Yusuf, S1
Al-Kahlili, F; Gilstring, Å; Haeggström, A; Risberg, D; Tullberg, U; Wallén, H1
Alonso, A; Bengtson, LGS; Chen, LY; Lutsey, PL; MacLehose, RF1
Abraham, NS; Noseworthy, PA; Sangaralingham, LR; Shah, ND; Yao, X1
Biagi, C; Conti, V; Donati, M; Melis, M; Monaco, L; Motola, D; Vaccheri, A; Venegoni, M1
Ambrosino, P; Di Minno, A; Di Minno, G; Di Minno, MN; Tremoli, E1
Bhatt, DL; Vaduganathan, M1
Chang, HY; Singh, S; Tang, W; Zhou, M1
Cong, J; Fromm, C; Ganetsky, M; Milling, TJ; Pallin, DJ; Singer, AJ1
Lip, GY; Potpara, TS1
Cangemi, DJ; Cipher, DJ; Feagins, LA; Krill, T; Spechler, SJ; Weideman, R1
Aikens, TH; Chernick, MR; Connolly, SJ; Ezekowitz, MD; Lip, GY; Parekh, A; Pogue, J; Reilly, PA; Wallentin, L; Yang, S; Yusuf, S1
Aribaud, A; Drouet, L; Eftekhari, P; Ginisty, S; Huy, PT; Legrand, M; Mateo, J; Payen, D1
Kouides, PA; Wychowski, MK1
Curtis, JA; Fellows, SE; Rosini, JM; Volz, EG1
Boesen, K; Ito, S; Kernan, L; Shirazi, F1
Dumkow, LE; Jennings, DL; Peters, M; Voss, JR1
Cirra, VR; Kamboj, J; Kamboj, R; Kottalgi, M; Shah, N1
Harinstein, LM; Morgan, JW; Russo, N1

Reviews

35 review(s) available for dabigatran and Gastrointestinal Hemorrhage

ArticleYear
Efficacy and Safety of the Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Nonvalvular Atrial Fibrillation and Cancer: A Systematic Review and Network Meta-analysis.
    Current problems in cardiology, 2022, Volume: 47, Issue:11

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Ischemic Stroke; Neoplasms; Network Meta-Analysis; Stroke; Treatment Outcome; Warfarin

2022
Gastrointestinal Bleeding on Oral Anticoagulation: What is Currently Known.
    Drug safety, 2022, Volume: 45, Issue:12

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Pyridones; Rivaroxaban; Stroke; Warfarin

2022
Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review.
    Advances in therapy, 2023, Volume: 40, Issue:1

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Gastrointestinal Hemorrhage; Humans; Rivaroxaban; Stroke; Venous Thromboembolism

2023
Gastrointestinal Bleeding Due to NOACs Use: Exploring the Molecular Mechanisms.
    International journal of molecular sciences, 2022, Nov-12, Volume: 23, Issue:22

    Topics: Administration, Oral; Anticoagulants; Dabigatran; Gastrointestinal Hemorrhage; Humans; Warfarin

2022
Proton Pump Inhibitors and Dabigatran Therapy: Impact on Gastric Bleeding and Dabigatran Plasma Levels.
    Seminars in thrombosis and hemostasis, 2019, Volume: 45, Issue:8

    Topics: Dabigatran; Gastrointestinal Hemorrhage; Humans; Proton Pump Inhibitors; Risk Factors

2019
Major gastrointestinal bleeding risk with direct oral anticoagulants: Does type and dose matter? - A systematic review and network meta-analysis.
    European journal of gastroenterology & hepatology, 2021, 12-01, Volume: 33, Issue:1S Suppl 1

    Topics: Administration, Oral; Anticoagulants; Dabigatran; Gastrointestinal Hemorrhage; Humans; Network Meta-Analysis; Rivaroxaban; Stroke; Warfarin

2021
The risk of gastrointestinal hemorrhage with non-vitamin K antagonist oral anticoagulants: A network meta-analysis.
    Medicine, 2021, Mar-19, Volume: 100, Issue:11

    Topics: Administration, Oral; Adult; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Enoxaparin; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Network Meta-Analysis; Observational Studies as Topic; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Venous Thromboembolism; Warfarin

2021
Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants.
    Cardiovascular drugs and therapy, 2022, Volume: 36, Issue:5

    Topics: Administration, Oral; Anticoagulants; Dabigatran; Gastrointestinal Hemorrhage; Humans; Rivaroxaban; Vitamin K

2022
Effects of rivaroxaban and warfarin on the risk of gastrointestinal bleeding and intracranial hemorrhage in patients with atrial fibrillation: Systematic review and meta-analysis.
    Clinical cardiology, 2021, Volume: 44, Issue:9

    Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Rivaroxaban; Stroke; Warfarin

2021
Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.
    Cardiovascular drugs and therapy, 2023, Volume: 37, Issue:2

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Network Meta-Analysis; Rivaroxaban; Stroke; Vitamin K

2023
Risk of gastrointestinal bleeding with direct oral anticoagulants: a systematic review and network meta-analysis.
    The lancet. Gastroenterology & hepatology, 2017, Volume: 2, Issue:2

    Topics: Administration, Oral; Anticoagulants; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Network Meta-Analysis; Risk Factors; Warfarin

2017
Risk of Gastrointestinal Bleeding in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants: A Systematic Review and Meta-analysis.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2017, Volume: 15, Issue:11

    Topics: Anticoagulants; Dabigatran; Gastrointestinal Hemorrhage; Humans; Risk Assessment; Rivaroxaban; Stroke; Thromboembolism

2017
Management of Oral Anticoagulation Therapy After Gastrointestinal Bleeding: Whether to, When to, and How to Restart an Anticoagulation Therapy.
    The Annals of pharmacotherapy, 2017, Volume: 51, Issue:11

    Topics: Anticoagulants; Dabigatran; Gastrointestinal Hemorrhage; Humans; Pyrazoles; Pyridones; Rivaroxaban; Thromboembolism; Warfarin

2017
Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis.
    Journal of Zhejiang University. Science. B, 2017, Volume: 18, Issue:7

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Bayes Theorem; Clinical Trials as Topic; Dabigatran; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Markov Chains; Middle Aged; Monte Carlo Method; Network Meta-Analysis; Odds Ratio; Pyridines; Randomized Controlled Trials as Topic; Risk; Thiazoles; Warfarin

2017
Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Stroke, 2017, Volume: 48, Issue:9

    Topics: Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Myocardial Infarction; Proportional Hazards Models; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Warfarin

2017
Differences in safety and efficacy of oral anticoagulants in patients with non-valvular atrial fibrillation: A Bayesian analysis.
    International journal of clinical practice, 2019, Volume: 73, Issue:4

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Bayes Theorem; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Proportional Hazards Models; Pyrazoles; Pyridones; Risk; Rivaroxaban; Stroke; Warfarin

2019
The Role of Acid Suppressants in the Prevention of Anticoagulant-Related Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis.
    Gut and liver, 2020, Jan-15, Volume: 14, Issue:1

    Topics: Adult; Aged; Antacids; Anticoagulants; Case-Control Studies; Cohort Studies; Coumarins; Dabigatran; Female; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Male; Middle Aged; Odds Ratio; Proton Pump Inhibitors; Treatment Outcome

2020
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Journal of the American Heart Association, 2019, 07-16, Volume: 8, Issue:14

    Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Neoplasms; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Venous Thromboembolism; Warfarin

2019
Gastrointestinal bleeding with the new oral anticoagulants--defining the issues and the management strategies.
    Thrombosis and haemostasis, 2013, Volume: 110, Issue:2

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Endoscopy; Gastrointestinal Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Warfarin

2013
Novel oral anticoagulants in gastroenterology practice.
    Gastrointestinal endoscopy, 2013, Volume: 78, Issue:2

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; Dabigatran; Gastrointestinal Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiophenes

2013
New anticoagulant and antiplatelet agents: a primer for the gastroenterologist.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2014, Volume: 12, Issue:2

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Cholangiopancreatography, Endoscopic Retrograde; Clopidogrel; Dabigatran; Drug Interactions; Fondaparinux; Gastrointestinal Hemorrhage; Humans; Piperazines; Platelet Aggregation Inhibitors; Polysaccharides; Prasugrel Hydrochloride; Proton Pump Inhibitors; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticlopidine

2014
[Gastrointestinal bleeding in cardiological patients].
    Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2013, Volume: 108, Issue:8

    Topics: Algorithms; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Dabigatran; Drug Monitoring; Gastrointestinal Hemorrhage; Heart Diseases; Humans; Metabolic Clearance Rate; Morpholines; Phenprocoumon; Platelet Aggregation Inhibitors; Platelet Transfusion; Rivaroxaban; Thiophenes; Vitamin K

2013
A comparison of results of the US food and drug administration's mini-sentinel program with randomized clinical trials: the case of gastrointestinal tract bleeding with dabigatran.
    JAMA internal medicine, 2014, Volume: 174, Issue:1

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Databases, Pharmaceutical; Gastrointestinal Hemorrhage; Humans; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration; Warfarin

2014
A Review of and Recommendations for the Management of Patients With Life-Threatening Dabigatran-Associated Hemorrhage: A Single-Center University Hospital Experience.
    Journal of intensive care medicine, 2015, Volume: 30, Issue:8

    Topics: Anticoagulants; Antidotes; Antithrombins; Charcoal; Dabigatran; Female; Gastrointestinal Hemorrhage; Hospitals, University; Humans; Intracranial Hemorrhages; Male; Multiple Organ Failure; Partial Thromboplastin Time; Renal Dialysis; Retrospective Studies; Severity of Illness Index; Stroke; Treatment Outcome

2015
[Gastrointestinal bleeding under treatment with new oral anticoagulants].
    MMW Fortschritte der Medizin, 2014, Feb-06, Volume: 156, Issue:2

    Topics: Administration, Oral; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intracranial Embolism; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Thiophenes; Thrombosis; Vitamin K; Warfarin

2014
Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: A meta-analysis of interventional trials.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2015, Volume: 47, Issue:5

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Thiazoles; Warfarin

2015
Management of anticoagulation in patients with acute gastrointestinal bleeding.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2015, Volume: 47, Issue:8

    Topics: Acenocoumarol; Acute Disease; Algorithms; Anticoagulants; Coagulants; Dabigatran; Endoscopy, Gastrointestinal; Gastrointestinal Hemorrhage; Humans; Rivaroxaban; Vitamin K; Warfarin

2015
New oral anticoagulants for patients with nonvalvular atrial fibrillation.
    JAAPA : official journal of the American Academy of Physician Assistants, 2015, Volume: 28, Issue:11

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles

2015
Gastrointestinal bleeding in patients receiving oral anticoagulation: Current treatment and pharmacological perspectives.
    Thrombosis research, 2015, Volume: 136, Issue:6

    Topics: Anticoagulants; Dabigatran; Gastrointestinal Hemorrhage; Humans; Proton Pump Inhibitors; Pyrazoles; Pyridones; Warfarin

2015
Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice: A Systematic Review and Meta-Analysis.
    Circulation. Cardiovascular quality and outcomes, 2016, Volume: 9, Issue:2

    Topics: Age Factors; Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Risk Factors; Stroke; Treatment Outcome; Warfarin

2016
The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies.
    British journal of clinical pharmacology, 2016, Volume: 82, Issue:1

    Topics: Administration, Oral; Anticoagulants; Dabigatran; Dose-Response Relationship, Drug; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Proton Pump Inhibitors; Rivaroxaban; Warfarin

2016
Re-Initiation of Dabigatran and Direct Factor Xa Antagonists After a Major Bleed.
    The American journal of medicine, 2016, Volume: 129, Issue:11S

    Topics: Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Pyrazoles; Pyridones; Recurrence; Risk Assessment; Rivaroxaban; Stroke; Thromboembolism

2016
Re-initiation of dabigatran and direct factor Xa antagonists after a major bleed.
    The American journal of emergency medicine, 2016, Volume: 34, Issue:11S

    Topics: Antithrombins; Clinical Decision-Making; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Practice Guidelines as Topic; Risk Assessment; Thromboembolism

2016
The risk of gastrointestinal bleeding in patients receiving dabigatran etexilate: a systematic review and meta-analysis of the literature.
    Annals of medicine, 2017, Volume: 49, Issue:4

    Topics: Aged; Aged, 80 and over; Antithrombins; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Prospective Studies; Vitamin K

2017
Treatment of dabigatran-associated bleeding: case report and review of the literature.
    Journal of pharmacy practice, 2013, Volume: 26, Issue:3

    Topics: Aged, 80 and over; Algorithms; Antithrombins; Benzimidazoles; Dabigatran; Factor VIIa; Factor VIII; Fibrinogen; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Male; Plasma; Pyridines; Renal Dialysis; Treatment Outcome

2013

Trials

3 trial(s) available for dabigatran and Gastrointestinal Hemorrhage

ArticleYear
Difference between the Upper and the Lower Gastrointestinal Bleeding in Patients Taking Nonvitamin K Oral Anticoagulants.
    BioMed research international, 2018, Volume: 2018

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Proton Pump Inhibitors; Pyrazoles; Pyridones; Rivaroxaban

2018
Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2017, Volume: 15, Issue:5

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Chemoprevention; Dabigatran; Embolism; Female; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Male; Prevalence; Prospective Studies; Stroke; Warfarin

2017
Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.
    Circulation, 2010, Nov-30, Volume: 122, Issue:22

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Embolism; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Pyridines; Risk Factors; Stroke; Treatment Outcome; Vitamin K; Warfarin

2010

Other Studies

116 other study(ies) available for dabigatran and Gastrointestinal Hemorrhage

ArticleYear
Mortality associated with the use of non-vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban.
    Cancer medicine, 2021, Volume: 10, Issue:20

    Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Cause of Death; Dabigatran; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Male; Middle Aged; Neoplasms; Rivaroxaban; Taiwan; Venous Thromboembolism

2021
Effectiveness and Safety of Dabigatran in Atrial Fibrillation Patients with Severe Obesity: a Real-World Retrospective Cohort Study.
    Journal of general internal medicine, 2022, Volume: 37, Issue:12

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Gastrointestinal Hemorrhage; Humans; Obesity, Morbid; Retrospective Studies; Stroke; Thromboembolism; Treatment Outcome; Warfarin

2022
Rivaroxaban Is Associated With Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants : A Nationwide Propensity Score-Weighted Study.
    Annals of internal medicine, 2021, Volume: 174, Issue:11

    Topics: Aged; Cohort Studies; Dabigatran; Digestive System Diseases; Factor Xa Inhibitors; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Iceland; Male; Propensity Score; Pyrazoles; Pyridones; Rivaroxaban; Ulcer

2021
Dabigatran Use after Argatroban for Heparin-induced Thrombocytopenia with Thrombosis: A Case Series and Literature Review.
    Annals of vascular surgery, 2022, Volume: 80

    Topics: Aged; Anticoagulants; Antithrombins; Arginine; Dabigatran; Drug Therapy, Combination; Fatal Outcome; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Count; Sulfonamides; Thrombocytopenia; Venous Thrombosis

2022
Clinical outcomes of dabigatran use in patients with non-valvular atrial fibrillation and weight >120 kg.
    Thrombosis research, 2021, Volume: 208

    Topics: Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Longitudinal Studies; Retrospective Studies

2021
Thrombotic events and rebleeding after hemorrhage in patients taking direct oral anticoagulants for non-valvular atrial fibrillation.
    PloS one, 2021, Volume: 16, Issue:11

    Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Male; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Thiazoles; Thrombosis

2021
Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023, Volume: 21, Issue:4

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Austria; Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Dabigatran; End Stage Liver Disease; Gastrointestinal Hemorrhage; Humans; Liver Neoplasms; Retrospective Studies; Severity of Illness Index; Vitamin K

2023
A new model to predict the risk of major gastrointestinal bleeding in patients on direct oral anticoagulants (dabigatran and rivaroxaban).
    British journal of clinical pharmacology, 2023, Volume: 89, Issue:1

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Humans; Retrospective Studies; Rivaroxaban

2023
Warfarin Is Associated With Higher Rates of Upper But Not Lower Gastrointestinal Bleeding Compared with Direct Oral Anticoagulants: A Population-Based Propensity-Weighted Cohort Study.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023, Volume: 21, Issue:2

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Gastrointestinal Hemorrhage; Humans; Retrospective Studies; Stroke; Warfarin

2023
Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain.
    Pharmacoepidemiology and drug safety, 2023, Volume: 32, Issue:4

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Rivaroxaban; Spain; Stroke; Tramadol

2023
Head-to-head efficacy and safety of rivaroxaban, apixaban, and dabigatran in an observational nationwide targeted trial.
    European heart journal. Cardiovascular pharmacotherapy, 2022, 12-15, Volume: 9, Issue:1

    Topics: Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Gastrointestinal Hemorrhage; Humans; Retrospective Studies; Rivaroxaban; Stroke

2022
Periprocedural Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant Undergoing a Digestive Endoscopy.
    The American journal of gastroenterology, 2023, 05-01, Volume: 118, Issue:5

    Topics: Administration, Oral; Adult; Anticoagulants; Atrial Fibrillation; Child; Cohort Studies; Dabigatran; Endoscopy, Gastrointestinal; Female; Gastrointestinal Hemorrhage; Humans; Male; Rivaroxaban

2023
Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation.
    Journal of thrombosis and thrombolysis, 2023, Volume: 55, Issue:3

    Topics: Administration, Oral; Adolescent; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Pyridones; Rivaroxaban; Stroke; Warfarin

2023
Retrospective analysis of gastrointestinal bleedings with direct oral anticoagulants reported to EudraVigilance.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:6

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Retrospective Studies; Rivaroxaban; Stroke

2023
Safety and mortality outcomes for direct oral anticoagulants in renal transplant recipients.
    PloS one, 2023, Volume: 18, Issue:5

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Kidney Transplantation; Retrospective Studies; Rivaroxaban; Stroke; Warfarin

2023
Gastrointestinal bleeding with direct oral anticoagulants in patients with atrial fibrillation and anaemia.
    Thrombosis research, 2023, Volume: 232

    Topics: Administration, Oral; Anemia; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Pyridones; Rivaroxaban; Stroke

2023
Direct oral anticoagulant- versus vitamin K antagonist-related gastrointestinal bleeding: Insights from a nationwide cohort.
    American heart journal, 2019, Volume: 216

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Cohort Studies; Dabigatran; Denmark; Female; Gastrointestinal Hemorrhage; Hospital Mortality; Humans; Logistic Models; Male; Pyrazoles; Pyridones; Rivaroxaban; United States; Vitamin K; Warfarin

2019
Life-threatening bleeding due to persistent dabigatran effect in a patient with sepsis despite idarucizumab therapy and haemodialysis.
    BMJ case reports, 2019, Aug-21, Volume: 12, Issue:8

    Topics: Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Dabigatran; Diagnosis, Differential; Fasciitis, Necrotizing; Gastrointestinal Hemorrhage; Humans; Leg; Male; Middle Aged; Renal Dialysis; Shock, Septic; Streptococcal Infections

2019
Use of Idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. A multicentric experience in Spain.
    Clinical transplantation, 2019, Volume: 33, Issue:12

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Atrial Fibrillation; Blood Coagulation; Cardiac Surgical Procedures; Dabigatran; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heart Transplantation; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors

2019
Redistribution of dabigatran after idarucizumab administration in a 90-year-old woman with renal failure due to persistent large intestinal bleeding.
    Polish archives of internal medicine, 2019, 12-23, Volume: 129, Issue:12

    Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antithrombins; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Renal Insufficiency

2019
The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulants.
    The American journal of emergency medicine, 2020, Volume: 38, Issue:6

    Topics: Aged; Aged, 80 and over; Dabigatran; Emergency Service, Hospital; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Registries; Warfarin

2020
Anticoagulant-related gastrointestinal bleeding: a real-life data analysis on bleeding profiles, frequency and etiology of patients receiving direct oral anticoagulants versus vitamin K antagonists.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2019, Volume: 70, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Vitamin K; Young Adult

2019
Real-world on-treatment and initial treatment absolute risk differences for dabigatran vs warfarin in older US adults.
    Pharmacoepidemiology and drug safety, 2020, Volume: 29, Issue:8

    Topics: Age Factors; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Dabigatran; Drug-Related Side Effects and Adverse Reactions; Female; Gastrointestinal Hemorrhage; Health Services for the Aged; Humans; Male; Medicare; Risk Factors; Stroke; United States; Warfarin

2020
Reweighting Oranges to Apples: Transported RE-LY Trial Versus Nonexperimental Effect Estimates of Anticoagulation in Atrial Fibrillation.
    Epidemiology (Cambridge, Mass.), 2020, Volume: 31, Issue:5

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Medicare; Mortality; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; United States; Warfarin

2020
Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2022, Volume: 20, Issue:2

    Topics: Administration, Oral; Adult; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Gastrointestinal Hemorrhage; Humans; Retrospective Studies; Warfarin

2022
Risks of post-colonoscopic polypectomy bleeding and thromboembolism with warfarin and direct oral anticoagulants: a population-based analysis.
    Gut, 2022, Volume: 71, Issue:1

    Topics: Aged; Anticoagulants; Blood Transfusion; Cohort Studies; Colonic Polyps; Colonoscopy; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Hong Kong; Humans; Male; Postoperative Complications; Pyrazoles; Pyridones; Retrospective Studies; Risk Assessment; Rivaroxaban; Thromboembolism; Warfarin

2022
Predicting major bleeding among hospitalized patients using oral anticoagulants for atrial fibrillation after discharge.
    PloS one, 2021, Volume: 16, Issue:3

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Intracranial Hemorrhages; Male; Pyrazoles; Pyridones; Regression Analysis; Rivaroxaban; Warfarin

2021
Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding.
    Cardiovascular drugs and therapy, 2022, Volume: 36, Issue:4

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Proton Pump Inhibitors; Rivaroxaban; Stroke; Upper Gastrointestinal Tract; Warfarin

2022
Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation : A Population-Based Cohort Study.
    Annals of internal medicine, 2021, Volume: 174, Issue:7

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Comparative Effectiveness Research; Dabigatran; Embolism; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Ischemic Stroke; Male; Propensity Score; Pyrazoles; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Treatment Outcome; Warfarin

2021
RHEDAR study: Determination of the risk of gastrointestinal hemorrhage in treatment with dabigatran, acenocoumarol and rivaroxaban.
    Journal of gastroenterology and hepatology, 2021, Volume: 36, Issue:10

    Topics: Acenocoumarol; Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Retrospective Studies; Rivaroxaban; Warfarin

2021
Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy.
    PloS one, 2021, Volume: 16, Issue:6

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Ischemic Stroke; Male; Middle Aged; Proton Pump Inhibitors; Republic of Korea; Risk; Rivaroxaban; Upper Gastrointestinal Tract; Warfarin

2021
Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding.
    JAMA network open, 2021, 08-02, Volume: 4, Issue:8

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Pyrazoles; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Treatment Outcome; United States; Warfarin

2021
The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran.
    Journal of thrombosis and haemostasis : JTH, 2017, Volume: 15, Issue:7

    Topics: Acute Kidney Injury; Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Atrial Fibrillation; Blood Coagulation; Dabigatran; Drug Administration Schedule; Fatal Outcome; Gastrointestinal Hemorrhage; Hemofiltration; Hemorrhage; Humans; Male; Renal Dialysis; Renal Replacement Therapy; Sepsis

2017
Comparative Effectiveness and Safety of Dabigatran and Rivaroxaban in Atrial Fibrillation Patients.
    Journal of the American Heart Association, 2017, Apr-24, Volume: 6, Issue:4

    Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Blood Transfusion; Cause of Death; Comparative Effectiveness Research; Dabigatran; Embolism; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Logistic Models; Male; Mortality; Myocardial Infarction; Propensity Score; Proportional Hazards Models; Retrospective Studies; Rivaroxaban; Stroke

2017
Intramural oesophageal haematoma-a rare complication of dabigatran.
    The New Zealand medical journal, 2017, Jun-02, Volume: 130, Issue:1456

    Topics: Aged, 80 and over; Antithrombins; Atrial Fibrillation; Dabigatran; Esophageal Perforation; Female; Gastrointestinal Hemorrhage; Gastroscopy; Hematoma; Hemoptysis; Humans; Mediastinal Diseases; Tomography, X-Ray Computed; Vomiting

2017
Choice of oral anticoagulants in older patients with non-valvular atrial fibrillation.
    British journal of hospital medicine (London, England : 2005), 2017, Jul-02, Volume: 78, Issue:7

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Craniocerebral Trauma; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Pyrazoles; Pyridines; Pyridones; Stroke; Thiazoles; Warfarin

2017
[Use of a Delphi survey to assess the hospital economic impact of innovative products: The example of idarucizumab a dabigatran-specific reversal agent].
    Annales pharmaceutiques francaises, 2017, Volume: 75, Issue:6

    Topics: Antibodies, Monoclonal, Humanized; Antithrombins; Dabigatran; Delphi Technique; Drug Costs; Economics, Hospital; France; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Surveys and Questionnaires

2017
Severity of Gastrointestinal Bleeding in Patients Treated with Direct-Acting Oral Anticoagulants.
    The American journal of medicine, 2018, Volume: 131, Issue:5

    Topics: Administration, Oral; Aged; Anticoagulants; Arteriovenous Malformations; Aspirin; Blood Transfusion; Case-Control Studies; Dabigatran; Diverticulum; Endoscopy, Gastrointestinal; Female; Gastrointestinal Hemorrhage; Hemorrhoids; Hospitalization; Humans; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Warfarin

2018
Bleeding with oral anticoagulant dabigatran is highly associated with occult cancers in atrial fibrillation patients.
    Future cardiology, 2018, Volume: 14, Issue:1

    Topics: Administration, Oral; Aged; Antithrombins; Atrial Fibrillation; Dabigatran; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Incidence; Japan; Male; Middle Aged; Neoplasms, Unknown Primary; Prevalence; Retrospective Studies; Risk Factors; Stroke; Survival Rate

2018
Treatment of gastrointestinal bleeding with idarucizumab in a patient receiving dabigatran.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2018, Feb-15, Volume: 75, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Dabigatran; Gastrointestinal Hemorrhage; Humans; Male; Treatment Outcome

2018
Severe obscure gastrointestinal bleeding successfully treated with idarucizumab.
    Revista espanola de enfermedades digestivas, 2018, Volume: 110, Issue:4

    Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Male

2018
Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran.
    Digestive diseases and sciences, 2018, Volume: 63, Issue:7

    Topics: Administration, Oral; Angiodysplasia; Anticoagulants; Antithrombins; Atrial Fibrillation; Colon; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intestinal Mucosa; Odds Ratio; Randomized Controlled Trials as Topic; Rectum; Retrospective Studies; Risk Factors; Treatment Outcome; Warfarin

2018
Ongoing redistribution of dabigatran necessitates repetitive application of idarucizumab.
    British journal of anaesthesia, 2018, Volume: 121, Issue:2

    Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Anticoagulants; Blood Coagulation Tests; Dabigatran; Emergency Medical Services; Female; Gastrointestinal Hemorrhage; Humans; Kidney Diseases

2018
Role of Hypertension and Other Clinical Variables in Prognostication of Patients Presenting to the Emergency Department With Major Bleeding Events.
    Critical pathways in cardiology, 2018, Volume: 17, Issue:3

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Blood Glucose; Blood Transfusion; Cardiovascular Diseases; Creatinine; Dabigatran; Emergency Service, Hospital; Epistaxis; Female; Gastrointestinal Hemorrhage; Hematuria; Hemoptysis; Hemorrhage; Humans; Hypertension; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Prognosis; Propensity Score; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Severity of Illness Index; Sex Factors; Thiazoles; Warfarin

2018
Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation.
    The American journal of cardiology, 2018, 09-01, Volume: 122, Issue:5

    Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Pyrazoles; Pyridones; Rivaroxaban; Spain; Stroke

2018
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study.
    Journal of the American Heart Association, 2018, 08-07, Volume: 7, Issue:15

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hepatic Insufficiency; Humans; Male; Proportional Hazards Models; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Warfarin

2018
Comparative safety and effectiveness of direct oral anticoagulants in patients with atrial fibrillation in clinical practice in Scotland.
    British journal of clinical pharmacology, 2019, Volume: 85, Issue:2

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Pulmonary Embolism; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Scotland; Stroke; Treatment Outcome

2019
Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding.
    JAMA, 2018, 12-04, Volume: 320, Issue:21

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Proton Pump Inhibitors; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Upper Gastrointestinal Tract; Warfarin

2018
Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding.
    Circulation, 2019, 02-05, Volume: 139, Issue:6

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Anticoagulants; Dabigatran; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Prospective Studies; Risk Assessment; United States; Venous Thromboembolism; Vitamin K

2019
Idarucizumab for Dabigatran-Related Gastrointestinal Bleeds.
    Circulation, 2019, 02-05, Volume: 139, Issue:6

    Topics: Antibodies, Monoclonal, Humanized; Dabigatran; Gastrointestinal Hemorrhage; Humans

2019
Efficacy of Direct Acting Oral Anticoagulants in Treatment of Left Ventricular Thrombus.
    The American journal of cardiology, 2019, 08-01, Volume: 124, Issue:3

    Topics: Adult; Aged; Blood Transfusion; Dabigatran; Echocardiography; Epistaxis; Factor Xa Inhibitors; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heart Ventricles; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Thrombosis; Ventricular Dysfunction, Left

2019
Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2020, Volume: 20, Issue:1

    Topics: Administration, Oral; Aged; Aged, 80 and over; Atrial Fibrillation; Cohort Studies; Dabigatran; Data Systems; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Male; Propensity Score; Rivaroxaban; Vitamin K

2020
Real World Outcomes Associated with Idarucizumab: Population-Based Retrospective Cohort Study.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2020, Volume: 20, Issue:2

    Topics: Adult; Antibodies, Monoclonal, Humanized; Cohort Studies; Dabigatran; Female; Gastrointestinal Hemorrhage; Hospital Mortality; Humans; Intracranial Hemorrhages; Male; Retrospective Studies; Severity of Illness Index; Treatment Outcome

2020
[Dabigatran as cause of severe gastrointestinal bleeding in a Jehovah's Witness patient].
    Ugeskrift for laeger, 2013, Feb-04, Volume: 175, Issue:6

    Topics: Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Transfusion; Critical Illness; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Jehovah's Witnesses; Plasma; Treatment Outcome; Treatment Refusal

2013
Dabigatran and postmarketing reports of bleeding.
    The New England journal of medicine, 2013, Apr-04, Volume: 368, Issue:14

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration; Warfarin

2013
Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.
    Journal of the American College of Cardiology, 2013, Jun-04, Volume: 61, Issue:22

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; Dabigatran; Denmark; Dose-Response Relationship, Drug; Drug Prescriptions; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hospitalization; Humans; Incidence; Intracranial Hemorrhages; Logistic Models; Male; Myocardial Infarction; Propensity Score; Proportional Hazards Models; Prospective Studies; Pulmonary Embolism; Pyridines; Registries; Stroke; Warfarin

2013
Extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: a single center experience.
    Clinical journal of the American Society of Nephrology : CJASN, 2013, Volume: 8, Issue:9

    Topics: Accidental Falls; Acute Disease; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Transfusion; Colonic Diseases; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Intestinal Perforation; Intestinal Volvulus; Leg Ulcer; Male; Renal Dialysis; Subarachnoid Hemorrhage

2013
[New oral anticoagulants and digestive hemorrhages].
    Presse medicale (Paris, France : 1983), 2014, Volume: 43, Issue:1

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Morpholines; Retrospective Studies; Rivaroxaban; Thiophenes

2014
Plasma dabigatran activity one week after discontinuation despite normal renal function.
    The American journal of medicine, 2013, Volume: 126, Issue:8

    Topics: Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans

2013
Anticoagulation-associated upper gastrointestinal haemorrhage.
    Internal medicine journal, 2013, Volume: 43, Issue:8

    Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Medical Audit; Upper Gastrointestinal Tract; Warfarin

2013
Gastrointestinal bleeding associated with dabigatran in a patient with panhypopituitarism.
    Wiener klinische Wochenschrift, 2014, Volume: 126, Issue:1-2

    Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Diagnosis, Differential; Embolism; Female; Gastrointestinal Hemorrhage; Humans; Hypopituitarism; Treatment Outcome

2014
Dabigatran-induced upper intestinal bleeding in a patient with chronic kidney disease.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013, Nov-13, Volume: 33, Issue:6

    Topics: Aged, 80 and over; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Diabetes Mellitus, Type 2; Erythrocyte Transfusion; Female; Gastrointestinal Hemorrhage; Glomerular Filtration Rate; Humans; Hypertension; Metabolic Clearance Rate; Renal Dialysis; Renal Insufficiency, Chronic; Thrombophilia; Urinary Tract Infections

2013
Multiple data sources, the best way to gather safety information about medications.
    JAMA internal medicine, 2014, Volume: 174, Issue:1

    Topics: Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Gastrointestinal Hemorrhage; Humans; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic

2014
Ischemic stroke and intestinal bleeding under dabigatran in metabolic myopathy.
    Cardiovascular therapeutics, 2013, Volume: 31, Issue:6

    Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Stroke

2013
Dabigatran Use in the Real World: A Multihospital System Experience.
    Journal of pharmacy practice, 2014, Volume: 27, Issue:4

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Dabigatran; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Inappropriate Prescribing; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Retrospective Studies

2014
Clinical experience of life-threatening dabigatran-related bleeding at a large, tertiary care, academic medical center: a case series.
    Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2014, Volume: 10, Issue:2

    Topics: Academic Medical Centers; Aged; Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Combined Modality Therapy; Dabigatran; Fatal Outcome; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Massachusetts; Middle Aged; Retrospective Studies; Severity of Illness Index; Tertiary Care Centers; Treatment Outcome

2014
Hip arthroplasty fatality related to dabigatran induced gastrointestinal haemorrhage.
    Annals of the Royal College of Surgeons of England, 2014, Volume: 96, Issue:1

    Topics: Aged; Antithrombins; Arthroplasty, Replacement, Hip; Benzimidazoles; Dabigatran; Fatal Outcome; Female; Gastrointestinal Hemorrhage; Humans; Pyridines; Venous Thromboembolism

2014
A novel approach to assess the spontaneous gastrointestinal bleeding risk of antithrombotic agents using Apc(min/+) mice.
    Thrombosis and haemostasis, 2014, Volume: 111, Issue:6

    Topics: Age Factors; Animals; Benzimidazoles; Clopidogrel; Dabigatran; Disease Models, Animal; Drug Evaluation, Preclinical; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Genes, APC; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Pyrazoles; Pyridines; Pyridones; Risk Factors; Ticlopidine; Warfarin

2014
No(AC) free lunches: promises and pitfalls of novel oral anticoagulants.
    The Israel Medical Association journal : IMAJ, 2014, Volume: 16, Issue:6

    Topics: Antithrombins; Benzimidazoles; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Pyridines

2014
Dabigatran etexilate linked to fatal gastrointestinal hemorrhage.
    The Israel Medical Association journal : IMAJ, 2014, Volume: 16, Issue:6

    Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; Dabigatran; Fatal Outcome; Female; Gastrointestinal Hemorrhage; Humans; Prothrombin Time; Pyridines

2014
Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran.
    The American journal of medicine, 2014, Volume: 127, Issue:12

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Drug Substitution; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; International Normalized Ratio; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Stroke; United States; United States Department of Veterans Affairs; Warfarin

2014
Anticoagulant-related gastrointestinal bleeding--could this facilitate early detection of benign or malignant gastrointestinal lesions?
    Annals of medicine, 2014, Volume: 46, Issue:8

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Early Detection of Cancer; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Incidence; Morpholines; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Thiophenes; Warfarin

2014
Risk of gastrointestinal bleeding with dabigatran: a head-to-head comparative study with rivaroxaban.
    Digestion, 2014, Volume: 90, Issue:2

    Topics: Aged; Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Morpholines; Retrospective Studies; Risk Factors; Rivaroxaban; Thiophenes

2014
Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
    Circulation, 2015, Jan-13, Volume: 131, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Comorbidity; Dabigatran; Dose-Response Relationship, Drug; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Kaplan-Meier Estimate; Kidney Diseases; Medicare; Proportional Hazards Models; Retrospective Studies; Risk; Socioeconomic Factors; Stroke; Treatment Outcome; United States; Warfarin

2015
Bleeding incidence and real-life prescribing practices with dabigatran use in an acute care setting.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2014, Volume: 29, Issue:11

    Topics: Adult; Antithrombins; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Incidence; Retrospective Studies

2014
The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.
    The American journal of gastroenterology, 2015, Volume: 110, Issue:2

    Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Enoxaparin; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Ischemic Attack, Transient; Longitudinal Studies; Male; Middle Aged; Morpholines; Patient Readmission; Prospective Studies; Pulmonary Embolism; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Venous Thrombosis; Warfarin; Withholding Treatment

2015
[Fatal bleeding diarrhoea during dabigatran etexilate therapy].
    Ugeskrift for laeger, 2014, Dec-15, Volume: 176, Issue:51

    Topics: Acute Kidney Injury; Aged; Antithrombins; Dabigatran; Diarrhea; Fatal Outcome; Gastrointestinal Hemorrhage; Humans; Male

2014
Management of dabigatran-induced bleeding with continuous venovenous hemodialysis.
    International journal of hematology, 2015, Volume: 101, Issue:6

    Topics: Aged; Antithrombins; Blood Coagulation Tests; Blood Transfusion; Dabigatran; Drug Overdose; Female; Gastrointestinal Hemorrhage; Humans; Renal Dialysis

2015
Gastrointestinal bleeding with dabigatran, a comparative study with warfarin: a multicenter experience.
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2015, Volume: 65, Issue:4

    Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Retrospective Studies; Risk Factors; Warfarin

2015
Evaluation of Dabigatran- and Warfarin-Associated Hemorrhagic Events Using the FDA-Adverse Event Reporting System Database Stratified by Age.
    International journal of medical sciences, 2015, Volume: 12, Issue:4

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Aging; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Kidney; Male; Middle Aged; Odds Ratio; United States; United States Food and Drug Administration; Warfarin

2015
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
    BMJ (Clinical research ed.), 2015, Apr-24, Volume: 350

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Male; Medicaid; Middle Aged; Morpholines; Patient Selection; Practice Patterns, Physicians'; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rivaroxaban; Thiophenes; United States; Warfarin

2015
Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study.
    BMJ (Clinical research ed.), 2015, Apr-24, Volume: 350

    Topics: Administration, Oral; Adult; Age Factors; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Male; Middle Aged; Morpholines; Observational Studies as Topic; Retrospective Studies; Risk Factors; Rivaroxaban; Thiophenes; United States; Warfarin

2015
Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.
    Gastroenterology, 2015, Volume: 149, Issue:3

    Topics: Aged; Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Female; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Hong Kong; Humans; Incidence; Male; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome

2015
Predictors of gastrointestinal bleeding among patients with atrial fibrillation after initiating dabigatran therapy.
    Pharmacotherapy, 2015, Volume: 35, Issue:6

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors

2015
The Real-World Treatment of Hemorrhages Associated With Dabigatran and Rivaroxaban: A Multicenter Evaluation.
    Critical pathways in cardiology, 2015, Volume: 14, Issue:2

    Topics: Aged; Aged, 80 and over; Antithrombins; Blood Coagulation Factors; Coagulants; Cohort Studies; Dabigatran; Epistaxis; Erythrocyte Transfusion; Factor VIIa; Factor VIII; Female; Fibrinogen; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Plasma; Platelet Transfusion; Recombinant Proteins; Retrospective Studies; Rivaroxaban

2015
Modified HAS-BLED Score and Risk of Major Bleeding in Patients Receiving Dabigatran and Rivaroxaban: A Retrospective, Case-Control Study.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2015, Volume: 30, Issue:7

    Topics: Aged; Aged, 80 and over; Anticoagulants; Case-Control Studies; Dabigatran; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Logistic Models; Male; Retrospective Studies; Risk Assessment; Risk Factors; Rivaroxaban

2015
Successful hemostasis and reversal of highly elevated PT/INR after dabigatran etexilate use in a patient with acute kidney injury.
    The American journal of emergency medicine, 2016, Volume: 34, Issue:4

    Topics: Acute Kidney Injury; Aged; Antithrombins; Dabigatran; Gastrointestinal Hemorrhage; Hemostatic Techniques; Humans; International Normalized Ratio; Male; Shock

2016
Dabigatran use in elderly patients with atrial fibrillation.
    Thrombosis and haemostasis, 2016, Volume: 115, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Blood Coagulation; Dabigatran; Databases, Factual; Drug Utilization Review; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Multivariate Analysis; Propensity Score; Proportional Hazards Models; Quebec; Risk Assessment; Risk Factors; Stroke; Treatment Outcome; Warfarin

2016
The options of reversal of a dabigatran effect.
    The American journal of emergency medicine, 2015, Volume: 33, Issue:12

    Topics: Acute Kidney Injury; Antithrombins; Dabigatran; Gastrointestinal Hemorrhage; Hemostatic Techniques; Humans; International Normalized Ratio; Male

2015
Emergency admissions for major haemorrhage associated with direct oral anticoagulants.
    Thrombosis research, 2015, Volume: 136, Issue:6

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Emergency Service, Hospital; Female; Gastrointestinal Hemorrhage; Hemodynamics; Hemorrhage; Hemostasis; Humans; Intracranial Hemorrhages; Male; Middle Aged; Patient Admission; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Venous Thrombosis

2015
Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation.
    Stroke, 2016, Volume: 47, Issue:2

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Asian People; Atrial Fibrillation; Brain Ischemia; Cardiovascular Diseases; Case-Control Studies; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Mortality; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Stroke; Taiwan; Warfarin

2016
The safety and persistence of non-vitamin-K-antagonist oral anticoagulants in atrial fibrillation patients treated in a well structured atrial fibrillation clinic.
    Current medical research and opinion, 2016, Volume: 32, Issue:4

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Cardiovascular Diseases; Dabigatran; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Patient Safety; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Treatment Outcome; Vitamin K

2016
Evaluation of Bleeding Events Requiring Hospitalization in Patients With Atrial Fibrillation Receiving Dabigatran, Warfarin, or Antiplatelet Therapy.
    Journal of pharmacy practice, 2017, Volume: 30, Issue:2

    Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Cohort Studies; Dabigatran; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Retrospective Studies; Warfarin

2017
A real world data of dabigatran etexilate: multicenter registry of oral anticoagulants in nonvalvular atrial fibrillation.
    Journal of thrombosis and thrombolysis, 2016, Volume: 42, Issue:3

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Dyspepsia; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Myocardial Infarction; Registries; Stroke; Warfarin

2016
Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study.
    European journal of internal medicine, 2016, Volume: 33

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Intracranial Hemorrhages; Israel; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Rivaroxaban; Stroke; Warfarin

2016
Persistent life-threatening hemorrhage after administration of idarucizumab.
    The American journal of emergency medicine, 2017, Volume: 35, Issue:1

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Atrial Fibrillation; Dabigatran; Duodenal Diseases; Embolization, Therapeutic; Gastrointestinal Hemorrhage; Humans; Male; Treatment Failure

2017
Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
    Journal of critical care, 2016, Volume: 36

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Factors; Cardiac Surgical Procedures; Dabigatran; Emergencies; Female; Gastrointestinal Hemorrhage; Heart Transplantation; Hemorrhage; Hemostatics; Heparin; Humans; Incidence; International Normalized Ratio; Intracranial Hemorrhages; Laparotomy; Male; Middle Aged; Preoperative Care; Pyrazoles; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Surgical Procedures, Operative; Thrombocytopenia; Thromboembolism; Vitamin K; Warfarin

2016
Gastrointestinal bleeding risk of non-vitamin K oral anticoagulants is similar to warfarin - a Japanese retrospective cohort study
.
    International journal of clinical pharmacology and therapeutics, 2016, Volume: 54, Issue:11

    Topics: Aged; Aged, 80 and over; Anticoagulants; Cohort Studies; Dabigatran; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Japan; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Vitamin K; Warfarin

2016
Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation.
    Journal of the American College of Cardiology, 2016, 09-27, Volume: 68, Issue:13

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Asian People; Atrial Fibrillation; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Retrospective Studies; Risk Assessment; Rivaroxaban; Stroke; Thromboembolism; Warfarin

2016
Management of Major Bleeding Related to Novel Oral Anticoagulant Agents Use in Frail Elderly Adults.
    Journal of the American Geriatrics Society, 2016, Volume: 64, Issue:10

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antidotes; Antithrombins; Dabigatran; Female; Frail Elderly; Gastrointestinal Hemorrhage; Hemostatic Techniques; Humans; Male; Renal Dialysis

2016
Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.
    JAMA internal medicine, 2016, 11-01, Volume: 176, Issue:11

    Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heart Valve Diseases; Humans; Kaplan-Meier Estimate; Male; Medicare; Retrospective Studies; Risk Factors; Rivaroxaban; Stroke; Treatment Outcome; United States

2016
[Gastrointestinal bleeding during treatment with non­vitamin K antagonist oral anticoagulants (NOACs) may be caused by malignant lesions].
    Lakartidningen, 2016, 11-07, Volume: 113

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Colonoscopy; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Male; Pilot Projects; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Vitamin K

2016
Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation.
    Journal of cardiology, 2017, Volume: 69, Issue:6

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Rivaroxaban; Warfarin

2017
Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study.
    Gastroenterology, 2017, Volume: 152, Issue:5

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Young Adult

2017
Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions.
    British journal of clinical pharmacology, 2017, Volume: 83, Issue:7

    Topics: Administration, Oral; Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Child; Child, Preschool; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Humans; Infant; Infant, Newborn; Male; Middle Aged; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stroke; Warfarin; World Health Organization; Young Adult

2017
Gastrointestinal Bleeding With Oral Anticoagulation: Understanding the Scope of the Problem.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2017, Volume: 15, Issue:5

    Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Gastrointestinal Hemorrhage; Humans; Neoplasms; Stroke; Warfarin

2017
Risk of Gastrointestinal Bleeding Among Dabigatran Users - A Self Controlled Case Series Analysis.
    Scientific reports, 2017, 01-20, Volume: 7

    Topics: Adult; Aged; Aged, 80 and over; Antithrombins; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Male; Middle Aged; Risk Assessment; Young Adult

2017
Management of Major Bleeding Events in Patients Treated With Dabigatran for Nonvalvular Atrial Fibrillation: A Retrospective, Multicenter Review.
    Annals of emergency medicine, 2017, Volume: 69, Issue:5

    Topics: Aged; Antithrombins; Atrial Fibrillation; Dabigatran; Emergency Service, Hospital; Erythrocyte Transfusion; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Retrospective Studies

2017
Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation.
    JAMA, 2017, Mar-21, Volume: 317, Issue:11

    Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Data Collection; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Observational Studies as Topic; Patient Selection; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Registries; Rivaroxaban; Stroke; Warfarin

2017
A Comparison of the Rate of Gastrointestinal Bleeding in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin.
    The American journal of gastroenterology, 2017, Volume: 112, Issue:5

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Blood Transfusion; Dabigatran; Female; Gastrointestinal Hemorrhage; Hemoglobins; Humans; Incidence; Male; Pulmonary Embolism; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Venous Thrombosis; Warfarin

2017
The use of dabigatran in elderly patients.
    Archives of internal medicine, 2011, Jul-25, Volume: 171, Issue:14

    Topics: Administration, Oral; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; Dabigatran; Device Removal; Fatal Outcome; Female; Gastrointestinal Hemorrhage; Humans; Pyridines; Shock, Hemorrhagic; Stroke

2011
Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.
    The Annals of pharmacotherapy, 2012, Volume: 46, Issue:4

    Topics: Acute Kidney Injury; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Creatinine; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; International Normalized Ratio; Patient Selection; Renal Dialysis

2012
Hemorrhagic gastritis with dabigatran in a patient with renal insufficiency.
    The Journal of emergency medicine, 2013, Volume: 44, Issue:2

    Topics: Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; Blood Component Transfusion; Dabigatran; Emergency Service, Hospital; Endoscopy, Gastrointestinal; Gastritis; Gastrointestinal Hemorrhage; Humans; Male; Plasma; Pyridines; Renal Insufficiency, Chronic

2013
Fatal gastrointestinal hemorrhage after a single dose of dabigatran.
    Clinical toxicology (Philadelphia, Pa.), 2012, Volume: 50, Issue:7

    Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Fatal Outcome; Gastrointestinal Hemorrhage; Humans; Male

2012
Reversal of dabigatran-induced bleeding with a prothrombin complex concentrate and fresh frozen plasma.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2012, Oct-01, Volume: 69, Issue:19

    Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Dabigatran; Fatal Outcome; Gastrointestinal Hemorrhage; Humans; Male; Multiple Organ Failure; Partial Thromboplastin Time; Plasma; Shock, Hemorrhagic

2012
Direct thrombin inhibitors: a case indicating benefit from 'plasmapheresis' in toxicity: a call for establishing "guidelines" in overdose and to find an "antidote"!
    American journal of therapeutics, 2012, Volume: 19, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antidotes; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Transfusion; Dabigatran; Female; Gastrointestinal Hemorrhage; Half-Life; Hematocrit; Hemoglobins; Humans; Ibuprofen; Middle Aged; Plasmapheresis; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Respiration, Artificial

2012